Traders sold shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) on strength during trading hours on Tuesday. $133.26 million flowed into the stock on the tick-up and $174.42 million flowed out of the stock on the tick-down, for a money net flow of $41.16 million out of the stock. Of all equities tracked, Intuitive Surgical had the 0th highest net out-flow for the day. Intuitive Surgical traded up $5.74 for the day and closed at $397.60

Several research firms have recently commented on ISRG. Wells Fargo & Co reissued a “buy” rating on shares of Intuitive Surgical in a research report on Monday, October 16th. Goldman Sachs Group reaffirmed a “buy” rating on shares of Intuitive Surgical in a research report on Saturday, November 18th. Wedbush reaffirmed an “outperform” rating and set a $353.33 target price on shares of Intuitive Surgical in a research report on Monday, September 25th. Zacks Investment Research raised Intuitive Surgical from a “hold” rating to a “buy” rating and set a $409.00 target price on the stock in a research report on Wednesday, January 3rd. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $410.00 target price on shares of Intuitive Surgical in a research report on Friday, January 5th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. Intuitive Surgical currently has an average rating of “Buy” and an average target price of $349.69.

The firm has a market capitalization of $47,170.00, a price-to-earnings ratio of 54.75, a price-to-earnings-growth ratio of 5.33 and a beta of 0.47.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.78. The business had revenue of $806.10 million for the quarter, compared to analyst estimates of $753.25 million. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The company’s revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the company earned $2.06 earnings per share. sell-side analysts predict that Intuitive Surgical, Inc. will post 7.85 earnings per share for the current fiscal year.

In other news, insider Craig H. Barratt sold 15,000 shares of the company’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $371.18, for a total value of $5,567,700.00. Following the sale, the insider now owns 7,500 shares in the company, valued at $2,783,850. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Marshall Mohr sold 6,000 shares of the company’s stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $372.22, for a total value of $2,233,320.00. Following the completion of the sale, the chief financial officer now owns 12,316 shares in the company, valued at approximately $4,584,261.52. The disclosure for this sale can be found here. Insiders sold 55,944 shares of company stock worth $21,432,971 over the last three months. Corporate insiders own 2.20% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. ETF Managers Group LLC purchased a new stake in shares of Intuitive Surgical in the second quarter worth about $110,000. Harvest Fund Management Co. Ltd purchased a new stake in shares of Intuitive Surgical in the second quarter worth about $120,000. Lincoln National Corp purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $200,000. MUFG Americas Holdings Corp purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $208,000. Finally, Advisors Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $209,000. Hedge funds and other institutional investors own 32.80% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Investors Sell Intuitive Surgical (ISRG) on Strength (ISRG)” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2018/01/11/investors-sell-intuitive-surgical-isrg-on-strength-isrg.html.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Receive News & Stock Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related stocks with our FREE daily email newsletter.